Debut Plus

₹202.24

▲ +0.12 +0.06%

As of 23 Oct 2026 · delayed

NSE Listed

Kilitch Drugs (India) Ltd. (KILITCH)

Volume: 1,44,523Avg Vol 1W: 87,878Avg Vol 1M: 1,08,567.0552W Range:₹117.25₹267.9
NSE BSE www.kilitch.com AI Report
Key Ratios
Checked 15h ago
Market Cap₹707 Cr
Current Price₹202.24
Previous Close₹202.12
High / Low (52w)₹267.9 / ₹117.25
Volume1,44,523
Avg Vol (1W)87,878
Avg Vol (1M)1,08,567.05
Stock P/E23.52
Book Value₹79.99
Dividend Yield0%
ROE10.79%
ROA6.38%
Revenue (TTM)₹247 Cr
Revenue Growth28.5%
Profit Margin12.67%
Total Debt₹28 Cr
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹8.6
P/B2.54
Debt / Equity0.29
50 DMA₹199.52
200 DMA₹176.42
Day change+0.06%
Price Chart
₹202.24▲ 1.05% · 1Y
₹261₹12417.6L
2025-10-27
2026-10-23

20-day avg volume: 1.1L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 51% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹47 Cr₹56 Cr₹61 Cr₹43 Cr₹49 Cr₹54 Cr₹90 Cr₹45 Cr
EBITDA₹11 Cr₹10 Cr₹15 Cr₹5 Cr₹11 Cr₹7 Cr₹22 Cr₹5 Cr
Net Profit₹9 Cr₹6 Cr₹10 Cr₹3 Cr₹8 Cr₹4 Cr₹15 Cr₹3 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹209 Cr₹56 Cr₹34 Cr₹38 Cr₹45 Cr₹72 Cr₹247 Cr₹41 Cr
EBITDA₹40 Cr₹16 Cr₹7 Cr₹11 Cr₹7 Cr₹20 Cr₹44 Cr₹7 Cr
Net Profit₹27 Cr₹11 Cr₹5 Cr₹9 Cr₹5 Cr₹14 Cr₹30 Cr₹5 Cr
EPS16.6—————8.91—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹144 Cr₹143 Cr₹203 Cr₹210 Cr₹220 Cr₹240 Cr₹313 Cr₹458 Cr
Total Liabilities₹21 Cr₹22 Cr₹74 Cr₹70 Cr₹69 Cr₹64 Cr₹112 Cr₹181 Cr
Equity₹123 Cr₹120 Cr₹129 Cr₹140 Cr₹151 Cr₹176 Cr₹200 Cr₹277 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹4 Cr₹7 Cr₹47 Cr₹8 Cr₹7 Cr₹6 Cr₹26 Cr₹34 Cr
Investing₹-14 Cr₹-10 Cr₹-38 Cr₹-15 Cr₹8 Cr₹-8 Cr₹-40 Cr₹-100 Cr
Financing₹17 Cr₹1 Cr₹2 Cr₹7 Cr₹-1 Cr₹9 Cr₹13 Cr₹82 Cr
Free Cash Flow₹4 Cr₹7 Cr₹47 Cr₹8 Cr₹7 Cr₹6 Cr₹26 Cr₹35 Cr
Shareholding
Promoter 63.77% Institutions 0.61% Public 35.62%
Efficiency & Working Capital
ROCE12%
Interest Coverage7.1
Dividend Payout—
Debtor Days186 d
Inventory Days18 d
Payable Days123 d
Cash Conversion Cycle81 d
Working Capital Days204 d
Shareholding Details

As of 2026-09-30

Promoter63.8%
FII0.1%
DII0.5%
Institutions0.6%
Public35.6%
Promoter Pledge0%
No. of Shareholders12,319
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters69.2%69.2%69.2%69.2%69.2%69.2%69.2%63.8%63.8%63.8%63.8%63.8%
FIIs0%0%0%0%0%0%0%0%0%0%0.1%0.1%
DIIs0%0%0%0%0%0%0%0%0%0%0%0.5%
Public30.8%30.8%30.8%30.8%30.8%30.8%30.8%36.2%36.2%36.2%36.1%35.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders9,0629,5259,6209,92010,1399,74910,37910,92912,04311,78512,62712,319
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Kilitch Company (pharma) LimitedShareholding of Promoter and Promoter Group37.9%1.33 Cr
Bhavin Mukund MehtaShareholding of Promoter and Promoter Group14.4%50,46,276
Mukund MehtaShareholding of Promoter and Promoter Group6.6%23,09,294
Mira Bhavin MehtaShareholding of Promoter and Promoter Group4.8%16,82,092
Dipak Kanayalal ShahPublic Shareholding3.2%11,02,000
Mukul Mahavir AgrawalPublic Shareholding1.3%4,70,000
Premilaben Rameshchandra ShahPublic Shareholding1.1%4,00,000
Board of Directors
NameDesignationYear
Mukund P MehtaChairman / Executive Director / Managing Director2026
Bhavin M MehtaE D & Wholetime Director2026
Mira MehtaExecutive Director & MD2026
VASUDEV KRISHNAMURTIIndependent Non Exe. Director2026
Venkita Subramanian RajanIndependent Non Exe. Director2026
DIPEN JAYANTILAL JAINIndependent Non Exe. Director2026
Pushpa NyoupaneCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
development and operations of Pharm₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10403535
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-13Board Meetings—
bonus2026-03-24Bonus issue 1:1—
bonus2026-03-241:11:1 Bonus Issue of Equity Shares
forthcoming—Book ClosureAGM
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202630024046
202600003030
2026300205
Insider / Designated-Person Trades

5 recent disclosure(s)

Mira Bhavin MehtaAcquisition · 8,41,046
Bhavin Mukund MehtaDisposal · 8,41,046
Bhavin Mukund MehtaAcquisition · 11,11,768
Mukund MehtaDisposal · 11,11,768
Mukund MehtaAcquisition · 11,11,768
Substantial Acquisitions (SAST)

4 disclosure(s)

-23/08/2024 · 8,41,046
Inter-se Transfer23/08/2024 · 8,41,046
Inter-se Transfer23/08/2024 · 8,41,046
NULL23/08/2024 · 8,41,046
Company Information
Incorporated1992
ChairmanMukund P Mehta
AuditorC Sharat & Associates
Investor Email[email protected]
🌐 www.kilitch.com ↗

📍 C-301/2 MIDC TTC Indl Area, Pawane Village, Thane, Maharashtra, 400705

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Khaitan Chemicals & Fertilizers Ltd.Khaitan (India)Ltd.Khandwala Securities Ltd.Kheria Autocomp LimitedKHFM Hospitality & Facility Mgt. Services Ltd.Kalyani Investment Company Ltd.Krishna Institute of Medical Sciences Ltd.Kingfa Science & Technology (India) Ltd.KIOCL LimitedKiran Vyapar Ltd.Kiri Industries LimitedKirloskar Ferrous Industries Ltd.All “K” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search